Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 8543561, 12 pages
http://dx.doi.org/10.1155/2016/8543561
Research Article

Protective Effect of Amphipterygium adstringens Extract on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice

1Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala s/n, 11400 Ciudad de México, Mexico
2Laboratorio de Inmunobiología, Carrera de Medicina, FES Iztacala, UNAM, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, 54090 Tlalnepantla, MEX, Mexico
3Laboratorio de Farmacognosia, UBIPRO, FES Iztacala, UNAM, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, 54090 Tlalnepantla, MEX, Mexico
4Unidad de Biomedicina, FES Iztacala, UNAM, Avenida de los Barrios Número 1, Colonia Los Reyes Iztacala, 54090 Tlalnepantla, MEX, Mexico

Received 18 March 2016; Accepted 3 July 2016

Academic Editor: Chang-Shik Yin

Copyright © 2016 Mario Rodriguez-Canales et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Balaha, S. Kandeel, and W. Elwan, “Garlic oil inhibits dextran sodium sulfate-induced ulcerative colitis in rats,” Life Sciences, vol. 146, pp. 40–51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Li, Y. Xu, C. Zhang et al., “Protective effect of Calculus Bovis Sativus on dextran sulphate sodium-induced ulcerative colitis in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 469506, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Algieri, A. Rodriguez-Nogales, N. Garrido-Mesa et al., “Intestinal anti-inflammatory activity of the Serpylli herba extract in experimental models of rodent colitis,” Journal of Crohn's and Colitis, vol. 8, no. 8, pp. 775–788, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Siegel, “Review article: explaining risks of inflammatory bowel disease therapy to patients,” Alimentary Pharmacology and Therapeutics, vol. 33, no. 1, pp. 23–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Hilsden, M. J. Verhoef, H. Rasmussen, A. Porcino, and J. C. C. Debruyn, “Use of complementary and alternative medicine by patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 17, no. 2, pp. 655–662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. V. Weizman, E. Ahn, R. Thanabalan et al., “Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 35, no. 3, pp. 342–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Algieri, A. Rodriguez-Nogales, M. E. Rodriguez-Cabezas, S. Risco, M. A. Ocete, and J. Galvez, “Botanical drugs as an emerging strategy in inflammatory bowel disease: a review,” Mediators of Inflammation, vol. 2015, Article ID 179616, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. E. J. Shin, M. J. Sung, H. J. Yang, M. S. Kim, and J.-T. Hwang, “Boehmeria nivea attenuates the development of dextran sulfate sodium-induced experimental colitis,” Mediators of Inflammation, vol. 2014, Article ID 231942, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Valatas, M. Vakas, and G. Kolios, “The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 305, no. 11, pp. G763–G785, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. R. Acevedo, M. D. Rojas, S. D. B. Arceo et al., “Effect of 6-nonadecyl salicylic acid and its methyl ester on the induction of micronuclei in polychromatic erythrocytes in mouse peripheral blood,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 609, no. 1, pp. 43–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Oviedo Chávez, T. Ramírez Apan, and M. Martínez-Vázquez, “Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes,” Journal of Pharmacy and Pharmacology, vol. 57, no. 9, pp. 1087–1091, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Gonzalez-Stuart, “Use of medicinal plants in Monterrey, Mexico,” Notulae Scientia Biologicae, vol. 2, no. 4, pp. 7–11, 2010. View at Google Scholar
  13. M. Martínez, Las Plantas Medicinales de México, Botas, Mexico City, Mexico, 6th edition, 1990.
  14. R. Mata, F. Calzada, A. Navarrete, F. del Rio, and G. Delgado, “Long-chain phenols from the bark of Amphypterygium adstringens,” Journal of Ethnopharmacology, vol. 34, no. 2-3, pp. 147–154, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Navarrete, I. Oliva, M. E. Sánchez-Mendoza, J. Arrieta, L. Cruz-Antonio, and G. Castañeda-Hernández, “Gastroprotection and effect of the simultaneous administration of Cuachalalate (Amphipterygium adstringens) on the pharmacokinetics and anti-inflammatory activity of diclofenac in rats,” Journal of Pharmacy and Pharmacology, vol. 57, no. 12, pp. 1629–1636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Oviedo-Chávez, T. Ramírez-Apan, M. Soto-Hernández, and M. Martínez-Vázquez, “Principles of the bark of Amphipterygium adstringens (Julianaceae) with anti-inflammatory activity,” Phytomedicine, vol. 11, no. 5, pp. 436–445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. E. Robles-Zepeda, C. A. Velázquez-Contreras, A. Garibay-Escobar, J. C. Gálvez-Ruiz, and E. Ruiz-Bustos, “Antimicrobial activity of northwestern mexican plants against Helicobacter pylori,” Journal of Medicinal Food, vol. 14, no. 10, pp. 1280–1283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Sardi-de Cássia Orlandi, I. P.-T. Alves, J. F. Höfling et al., “Effect of plants used in Mexican traditional medicine on Candida albicans biofilm,” in Microorganisms in Industry and Environment: From Scientific and Industrial Research to Consumer Products, A. Mendez-Vilas, Ed., pp. 476–478, World Scientific, London, UK, 2009. View at Publisher · View at Google Scholar
  19. M. Canales, T. Hernández, J. Caballero et al., “Informant consensus factor and antibacterial activity of the medicinal plants used by the people of San Rafael Coxcatlán, Puebla, México,” Journal of Ethnopharmacology, vol. 97, no. 3, pp. 429–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. B. M. N. Fernández, Análisis de la Dinámica de Comunidades Vegetales con Relación a la Evolución del Paisaje, en la Zona Semiárida de Coxcatlán, Puebla, Facultad de Ciencias, División de Estudios de Posgrado, UNAM, 1999.
  21. P. N. Okusa, O. Penge, M. Devleeschouwer, and P. Duez, “Direct and indirect antimicrobial effects and antioxidant activity of Cordia gilletii De Wild (Boraginaceae),” Journal of Ethnopharmacology, vol. 112, no. 3, pp. 476–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. V. L. Singleton, R. Orthofer, and R. M. Lamuela-Raventós, “Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent,” Methods in Enzymology, vol. 299, pp. 152–178, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. P. K. Ramamoorthy and A. Bono, “Antioxidant activity, total phenolic and flavonoid content of Morinda citrifolia fruit extracts from various extraction processes,” Journal of Engineering Science and Technology, vol. 2, no. 1, pp. 70–80, 2007. View at Google Scholar
  24. R. Scherer and H. T. Godoy, “Effects of extraction methods of phenolic compounds from Xanthium strumarium L. and their antioxidant activity,” Revista Brasileira de Plantas Medicinais, vol. 16, no. 1, pp. 41–46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Al-Fatimi, M. Wurster, G. Schröder, and U. Lindequist, “Antioxidant, antimicrobial and cytotoxic activities of selected medicinal plants from Yemen,” Journal of Ethnopharmacology, vol. 111, no. 3, pp. 657–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Hasnat, M. Pervin, K. M. Cha, S. K. Kim, and B. O. Lim, “Anti-inflammatory activity on mice of extract of Ganoderma lucidum grown on rice via modulation of MAPK and NF-κB pathways,” Phytochemistry, vol. 114, pp. 125–136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Şengul, S. Isik, B. Aslim, G. Ucar, and A. E. Demirbag, “The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis,” Digestive Diseases and Sciences, vol. 56, no. 3, pp. 707–714, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Xing, C. You, K. Dong et al., “Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats,” International Immunopharmacology, vol. 15, no. 3, pp. 524–531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. B. Z. Rodríguez, R. G. Álvarez, D. Guanche et al., “Antioxidant mechanism is involved in the gastroprotective effects of ozonized sunflower oil in ethanol-induced ulcers in rats,” Mediators of Inflammation, vol. 2007, Article ID 65873, 6 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Bilici, H. Süleyman, Z. N. Banoğlu et al., “Melatonin prevents ethanol-induced gastric mucosal damage possibly due to its antioxidant effect,” Digestive Diseases and Sciences, vol. 47, no. 4, pp. 856–861, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Kanter, H. Demir, C. Karakaya, and H. Ozbek, “Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats,” World Journal of Gastroenterology, vol. 11, no. 42, pp. 6662–6666, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Perrier and P. Rutgeerts, “Cytokine blockade in inflammatory bowel diseases,” Immunotherapy, vol. 3, no. 11, pp. 1341–1352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Biasi, G. Leonarduzzi, P. I. Oteiza, and G. Poli, “Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets,” Antioxidants and Redox Signaling, vol. 19, no. 14, pp. 1711–1747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Fiorino, H. Szabò, W. Fries, A. Malesci, L. Peyrin-Biroulet, and S. Danese, “Adalimumab in Crohn's disease: tips and tricks after 5 years of clinical experience,” Current Medicinal Chemistry, vol. 18, no. 8, pp. 1230–1238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. H. K. Ki, A. Murakami, R. Hayashi, and H. Ohigashi, “Interleukin-1β targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis,” Biochemical and Biophysical Research Communications, vol. 337, no. 2, pp. 647–654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. T. L. Denning, Y.-C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran, “Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses,” Nature Immunology, vol. 8, no. 10, pp. 1086–1094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S.-J. Ko, Y. Bu, J. Bae et al., “Protective effect of Laminaria japonica with probiotics on murine colitis,” Mediators of Inflammation, vol. 2014, Article ID 417814, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. Kelm, M. G. Nair, G. M. Strasburg, and D. L. DeWitt, “Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn.,” Phytomedicine, vol. 7, no. 1, pp. 7–13, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Zheng and S. Y. Wang, “Antioxidant activity and phenolic compounds in selected herbs,” Journal of Agricultural and Food Chemistry, vol. 49, no. 11, pp. 5165–5170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. M. R. Cholbi, M. Paya, and M. J. Alcaraz, “Inhibitory effects of phenolic compounds on CCl4-induced microsomal lipid peroxidation,” Experientia, vol. 47, no. 2, pp. 195–199, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, “Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships,” Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572–584, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. B. N. Singh, S. Shankar, and R. K. Srivastava, “Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications,” Biochemical Pharmacology, vol. 82, no. 12, pp. 1807–1821, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Mochizuki and N. Hasegawa, “(-)-Epigallocatechin-3-gallate reduces experimental colon injury in rats by regulating macrophage and mast cell,” Phytotherapy Research, vol. 24, supplement 1, pp. S120–S122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. S. Al-Rejaie, H. M. Abuohashish, M. M. Al-Enazi, A. H. Al-Assaf, M. Y. Parmar, and M. M. Ahmed, “Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats,” World Journal of Gastroenterology, vol. 19, no. 34, pp. 5633–5644, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Dou, J. Zhang, A. Sun et al., “Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling,” British Journal of Nutrition, vol. 110, no. 4, pp. 599–608, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Azuma, M. Shigeshiro, M. Kodama, S. Tanabe, and T. Suzuki, “Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice,” Journal of Nutrition, vol. 143, no. 6, pp. 827–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. P. C. Calder, “Fatty acids and inflammation: the cutting edge between food and pharma,” European Journal of Pharmacology, vol. 668, supplement 1, pp. S50–S58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. K.-B. Kim, Y. A. Nam, H. S. Kim, A. W. Hayes, and B.-M. Lee, “α-Linolenic acid: nutraceutical, pharmacological and toxicological evaluation,” Food and Chemical Toxicology, vol. 70, pp. 163–178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Hassan, A. Ibrahim, K. Mbodji et al., “An α-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-κB in rats with TNBS-induced colitis,” Journal of Nutrition, vol. 140, no. 10, pp. 1714–1721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Ibrahim, M. Aziz, A. Hassan et al., “Dietary α-linolenic acid-rich formula reduces adhesion molecules in rats with experimental colitis,” Nutrition, vol. 28, no. 7-8, pp. 799–802, 2012. View at Publisher · View at Google Scholar · View at Scopus